Top Markets
#1 Black Phoenix Black Phoenix +735.13%
#2 Beam Beam +32.89%
#3 SAFEcoin SAFEcoin +20.16%
#4 TENDIES TENDIES +17.65%
#5 Bless Bless +17.64%
#6 Biconomy Biconomy +16.89%
#7 EfficientFrontier EfficientFrontier +15.58%
#8 pipedog pipedog +15.03%
#9 THORChain THORChain +14.76%
#10 Versatize Coin Versatize Coin +12.50%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Corporativo Fragua, S.A.B. de C.V. Corporativo Fragua, S.A.B. de C.V.

Corporativo Fragua, S.A.B. de C.V.

FRAGUAB
Clasificación en acciones #5633
Corporativo Fragua, S.A.B. de C.V. oversees a chain of Superfarmacia drugstores... Corporativo Fragua, S.A.B. de C.V. oversees a chain of Superfarmacia drugstores located throughout Mexico. These retail outlets provide a wide array of products, including medicines, perfumes, photography supplies, household goods, and diverse food items such as fresh produce, baked goods, and deli meats. Furthermore, the company engages in the processing and sale of photographic apparatus and offers freight services. Established in 1942, Corporativo Fragua, S.A.B. de C.V. has its main office situated in Guadalajara, Mexico.
Precio por acción
$26.66
Última sincronización: 2026-08-26
Capitalización bursátil
$2.55B
Cambio (1 día)
1.19%
Cambio (1 año)
-8.41%
País
MX
Comercio Corporativo Fragua, S.A.B. de C.V. (FRAGUAB)

Categoría

Healthcare
Ganancias de Corporativo Fragua, S.A.B. de C.V. (FRAGUAB)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Corporativo Fragua, S.A.B. de C.V., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Corporativo Fragua, S.A.B. de C.V. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK